CTEV CLARITEV CORP CLASS A
Permanent stock page ↗Consumer Discretionary · Russell 2000
Next earnings: Mon 9 Nov 2026 · before market open
What 9 analyst firms say about CLARITEV CORP CLASS A: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
8 rated views · 9 analyst/firm records · 9 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8046
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8033
Recent analyst activity · last 90 days
Our tracked history has 8 reports on CTEV from 7 analyst firms in the last 90 days (9 firms in the past year).
Comparing each firm's latest target with its previous one: 2 raised their price target and 3 left it unchanged.
No firm's latest available rating differs from its previous one.
Latest observed target change: Barclays raised its target from $28.00 (set 24 Apr 2026) to $40.00 on 20 Aug 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Barclays | Glen Santangelo | Buy | 20 Aug 2026 | 40.00 USD |
| Canaccord Genuity | Richard Close | Buy | 10 Aug 2026 | 43.00 USD |
| Citigroup | Daniel Grosslight | Buy | 10 Aug 2026 | 45.00 USD |
| Guggenheim | Jason Cassorla | Buy | 7 Aug 2026 | 44.00 USD |
| Piper Sandler | Jessica E Tassan | Buy | 3 Jun 2026 | 73.00 USD |
| UBS | Unnamed analyst | Buy | 24 Feb 2026 | — |
| Weiss Ratings | Unnamed analyst | — | 21 Sep 2026 | — |
| Wells Fargo | Stan Berenshteyn | Hold | 12 Aug 2026 | 30.00 USD |
| Data feed RESEARCH | Research Team | Hold | 13 Aug 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:59 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.